DTG are delighted to announce the launch of our new digital product designed to transform the pace of Carbon decision-making for sustainable manufacturing – PHASE.

PHASE is for Pharma leaders who have initiated product Carbon reporting and Life Cycle Assessment but now face growing pressure to go further – to model, predict and optimise the impact of carbon-reduction initiatives for securing Market Access and delivering Sustainability commitments.  That’s because

The PHASE platform turns high volumes of static product LCA data into an instant carbon decision-making tool.

Tailored to your company’s portfolio, strategic priorities and operational reality, PHASE instantly:

–  Identifies carbon hotspots across your supply chains

–  Models scenarios and predicts the impact of your in-flight carbon initiatives

– Generates live, dynamic visuals to explore “what if?” questions – available to any team

Giving you a clear, real-time view of where value is being created and where impact is still to be unlocked – without the need for LCA expertise and data analysis resource.

PHASE was created in direct response to a very specific problem that Heads of Sustainability and Manufacturing have been telling us they are trying to manage: existing methods of Life Cycle Assessment for individual medicines have been adequate for reporting but aren’t dynamic enough for scenario planning the numerous carbon-reduction choices across formulation, manufacturing and the supply chain.

…and that problem is becoming critical as key markets begin requiring product-level carbon data and carbon-reduction plans for reimbursement decisions.

As a team of former Pharma manufacturing, operational and engineering leaders, we designed PHASE to get Sustainability leaders ready for all the “What if?” carbon questions that are coming your way for Market Access and for delivering on corporate sustainability commitments.

To request a demonstration of PHASE and to see how it is tailored to your company’s focus, click here.